Advances in Nutritional Genomics and its Use in Personalized Nutrition for Treatment Obesity
DOI:
https://doi.org/10.47187/cssn.Vol15.Iss1.280Keywords:
Nutritional genomics, obesity, personalized nutrition, nutraceuticsAbstract
Introduction. This literature review explores advances in nutritional genomics and its application in personalized nutrition to address obesity. Considering the complexity of the human genome and genetic susceptibilities to diseases like obesity, personalized nutrition emerges as a promising solution for this multifactorial disease that impacts global public health. Objective. The aim of the study is to identify the most effective nutraceuticals in personalized nutrition to mitigate or treat obesity through specific dietary adjustments based on individual genetics. Methodology. A non-systematic review of scientific literature published between 2019 and 2023 was conducted, selecting studies based on criteria of relevance, accessibility, and timeliness. Of the 82 articles evaluated, 40 met the inclusion criteria. Results. The selected studies highlight the importance of compounds such as quercetin, curcumin, resveratrol, and anthocyanins in modulating the genetic and metabolic response to obesity. These nutraceuticals have been demonstrated to be effective in reducing adiposity and related inflammation. Discussion. Nutrigenetics and nutrigenomics are essential for personalizing nutrition, as individual genetic variability significantly affects the response to different diets and treatments, justifying a personalized approach that considers the specific genotype of the individual.
Conclusion. Integrating nutraceuticals into the diet based on the genetic profile may be key to the effective management and treatment of obesity. Research points towards a shift to personalized nutrition, emphasizing the need for more studies and their implementation in clinical and dietary practices.
Downloads
References
De Luis D, Izaola O, Primo D. Nutrición personalizada, una herramienta para el tratamiento del paciente obeso. Nutr Clin Med [Internet]. 2021;15(3):138–52.
World Health Organization. Obesity and overweight. 2021.
Bray GA, Kim KK, Wilding JPH. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obesity Reviews. el 1 de julio de 2017;18(7):715–23.
Kaufer-Horwitz M, Pérez Hernández JF. La obesidad: aspectos fisiopatológicos y clínicos. INTER DISCIPLINA. el 16 de diciembre de 2021;10(26):147.
Sato S, Mukai Y. Modulation of chronic inflammation by quercetin: The beneficial effects on obesity. Vol. 13, Journal of Inflammation Research. Dove Medical Press Ltd; 2020. p. 421–31.
Marcum JA. Nutrigenetics/Nutrigenomics, Personalized Nutrition, and Precision Healthcare. Curr Nutr Rep. el 1 de diciembre de 2020;9(4):338–45.
Aruoma OI, Hausman-Cohen S, Pizano J, Schmidt MA, Minich DM, Joffe Y, et al. Personalized Nutrition: Translating the Science of NutriGenomics Into Practice: Proceedings From the 2018 American College of Nutrition Meeting. J Am Coll Nutr. el 19 de mayo de 2019;38(4):287–301.
Guo Y, Huang Z, Sang D, Gao Q, Li Q. The Role of Nutrition in the Prevention and Intervention of Type 2 Diabetes. Vol. 8, Frontiers in Bioengineering and Biotechnology. Frontiers Media S.A.; 2020.
Chaudhary N, Kumar V, Sangwan P, Pant NC, Saxena A, Joshi S, et al. Personalized Nutrition and -Omics. En: Comprehensive Foodomics. Elsevier; 2021. p. 495–507.
Montealegre M. Nutrigenómica y Nutrigenética: el Futuro de la Nutrición. Revista Ciencia y Salud Integrando Conocimientos. junio de 2019;3(3):15–6.
Zapata-Bravo E, Pacheco-Orozco RA, Payán-Gómez C, López-Rippe J. Abordaje nutrigenómico de la obesidad: ¿dónde estamos? Revista de Nutrición Clínica y Metabolismo. el 15 de enero de 2021;4(1):25–34.
Vega B. La Nutrigenética en el Tratamiento Personalizado de la Obesidad y del Riesgo Metabólico. Estudio ONTIME (Obesidad, Nutrigenética, Tiempo, Mediterránea) [Doctoral]. [Murcia]: Universidad de Murcia; 2019.
Mejia-Montilla J, Reyna-Villasmil N, Bravo-Henríquez A, Fernández-Ramírez A, Reyna-Villasmil E, Revisión [. Obesidad, nutrición e información genética. 2021;
Patel P, Selvaraju V, Babu JR, Wang X, Geetha T. Racial Disparities in Methylation of NRF1, FTO, and LEPR Gene in Childhood Obesity. Genes (Basel). el 1 de noviembre de 2022;13(11).
Mullins VA, Bresette W, Johnstone L, Hallmark B, Chilton FH. Genomics in personalized nutrition: Can you “eat for your genes”? Vol. 12, Nutrients. MDPI AG; 2020. p. 1–23.
Czogała W, Czogała M, Strojny W, Watorą G, Wołkow P, Wójcik M, et al. Methylation and expression of FTO and PLAG1 genes in childhood obesity: Insight into anthropometric parameters and glucose–lipid metabolism. Nutrients. el 1 de mayo de 2021;13(5).
Rushing A, Sommer EC, Zhao S, Po’E EK, Barkin SL. Salivary epigenetic biomarkers as predictors of emerging childhood obesity. BMC Med Genet. el 14 de febrero de 2020;21(1).
Espinoza García AS, Martínez Moreno AG, Reyes Castillo Z. The role of ghrelin and leptin in feeding behavior: Genetic and molecular evidence. Endocrinol Diabetes Nutr. el 1 de noviembre de 2021;68(9):654–63.
González-Becerra K, Ramos-Lopez O, Barrón-Cabrera E, Riezu-Boj JI, Milagro FI, Martínez-López E, et al. Fatty acids, epigenetic mechanisms and chronic diseases: A systematic review. Lipids Health Dis. el 15 de octubre de 2019;18(1).
Samblas M, Milagro FI, Martínez A. DNA methylation markers in obesity, metabolic syndrome, and weight loss. Vol. 14, Epigenetics. Taylor and Francis Inc.; 2019. p. 421–44.
Cahuana-Berrocal J, Donado-Gamez G, Barroso-Martínez L, González-Redondo N, Lizarazu-Diazgranados I, Iglesias-Acosta J. Epigenética y Enfermedades Crónicas no Transmisibles. Archivos de Medicina [Internet]. 2019;15(4:5):5. Disponible en: www.archivosdemedicina.com
Xu L, Yeung MHY, Yau MYC, Lui PPY, Wong CM. Role of Histone Acetylation and Methylation in Obesity. Curr Pharmacol Rep. el 15 de junio de 2019;5(3):196–203.
Malodobra-Mazur M, Cierzniak A, Dobosz T. Oleic acid influences the adipogenesis of 3T3-L1 cells via DNA Methylation and may predispose to obesity and obesity-related disorders. Lipids Health Dis. el 28 de diciembre de 2019;18(1).
Ortiz-Dosal A, Rodil-García P, Salazar-Olivo LA. Circulating microRNAs in human obesity: a systematic review. Vol. 24, Biomarkers. Taylor and Francis Ltd; 2019. p. 499–509.
Deepika, Maurya PK. Health Benefits of Quercetin in Age-Related Diseases. Vol. 27, Molecules. MDPI; 2022.
Nettore IC, Rocca C, Mancino G, Albano L, Amelio D, Grande F, et al. Quercetin and its derivative Q2 modulate chromatin dynamics in adipogenesis and Q2 prevents obesity and metabolic disorders in rats. Journal of Nutritional Biochemistry. el 1 de julio de 2019;69:151–62.
Pérez I, Castrejón V, Soto M, Rubio M, Manzano L, Guarner V. Oxidative Stress, Plant Natural Antioxidants, and Obesity. Int J Mol Sci. 2021;22(4).
Afarideh M, Thaler R, Khani F, Tang H, Jordan KL, Conley SM, et al. Global epigenetic alterations of mesenchymal stem cells in obesity: the role of vitamin C reprogramming. Epigenetics. 2021;16(7):705–17.
Otocka-Kmiecik A. Effect of Carotenoids on Paraoxonase-1 Activity and Gene Expression. Nutrients. el 1 de julio de 2022;14(14).
Zhu Y, Liu R, Shen Z, Cai G. Combination of luteolin and lycopene effectively protect against the “two-hit” in NAFLD through Sirt1/AMPK signal pathway. Life Sci. el 1 de septiembre de 2020;256.
Yu HR, Sheen JM, Tiao MM, Tain YL, Chen CC, Lin IC, et al. Resveratrol Treatment Ameliorates Leptin Resistance and Adiposity Programed by the Combined Effect of Maternal and Post-Weaning High-Fat Diet. Mol Nutr Food Res. el 1 de julio de 2019;63(13).
Chen Y, Wu R, Chen W, Liu Y, Liao X, Zeng B, et al. Curcumin prevents obesity by targeting TRAF4‐induced ubiquitylation in m 6 A‐dependent manner. EMBO Rep. el 5 de mayo de 2021;22(5).
Escalante-Aburto A, Mendoza-Córdova MY, Mahady GB, Luna-Vital DA, Gutiérrez-Uribe JA, Chuck-Hernández C. Consumption of dietary anthocyanins and their association with a reduction in obesity biomarkers and the prevention of obesity. Trends Food Sci Technol. el 1 de octubre de 2023;140.
Sofía L, Guerrero V, Armando D, Portillo V, Wesche-Ebeling P, Abascal LT, et al. The purpose of nutrigenomics and nutraceuticals at the prevention of cardiovascular diseases; review. Revista Cubana de Cardiología y Cirugía Cardiovascular . 2019;25(3).
Horne JR, Gilliland JA, O’Connor CP, Seabrook JA, Madill J. Change in Weight, BMI, and Body Composition in a Population-Based Intervention Versus Genetic-Based Intervention: The NOW Trial. Obesity. el 1 de agosto de 2020;28(8):1419–27.
Navas-Carretero S, San-Cristobal R, Alvarez-Alvarez I, Celis-Morales C, Livingstone KM, O’donovan CB, et al. Interactions of Carbohydrate Intake and Physical Activity with Regulatory Genes Affecting Glycaemia: A Food4Me Study Analysis. Lifestyle Genom. el 1 de septiembre de 2021;14(3):63–72.
Bordoni L, Gabbianelli R. Primers on nutrigenetics and nutri(epi)genomics: Origins and development of precision nutrition. Vol. 160, Biochimie. Elsevier B.V.; 2019. p. 156–71.
Livingstone KM, Celis-Morales C, Navas-Carretero S, San-Cristobal R, Forster H, Woolhead C, et al. Personalised nutrition advice reduces intake of discretionary foods and beverages: findings from the Food4Me randomised controlled trial. International Journal of Behavioral Nutrition and Physical Activity. el 1 de diciembre de 2021;18(1).
Bush CL, Blumberg JB, El-Sohemy A, Minich DM, Ordovás JM, Reed DG, et al. Toward the Definition of Personalized Nutrition: A Proposal by The American Nutrition Association. Vol. 39, Journal of the American College of Nutrition. Routledge; 2020. p. 5–15.
Adams SH, Anthony JC, Carvajal R, Chae L, Khoo CSH, Latulippe ME, et al. Perspective: Guiding Principles for the Implementation of Personalized Nutrition Approaches That Benefit Health and Function. Vol. 11, Advances in Nutrition. Oxford University Press; 2020. p. 25–34.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 LA CIENCIA AL SERVICIO DE LA SALUD Y NUTRICIÓN
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
